SCISPARC: SUBSIDIARY NEUROTHERA LABS REPORTS POSITIVE PROGRESS IN FDA-APPROVED PHASE IIB CLINICAL TRIAL FOR TOURETTE SYNDROME

Reuters · 2d ago

Please log in to view news